Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry

EuroIntervention 2016;11:1468-1474. DOI: 10.4244/EIJV11I13A285

Andrés Iñiguez
Andrés Iñiguez1, MD; Sorin J. Brener2,3*, MD; Victor A. Jiménez1, MD; Akiko Maehara3,4, MD; Gary S. Mintz3, MD; Ke Xu3, PhD; Giora Weisz3,4,5, MD; Alexandra J. Lansky6, MD; Bernard De Bruyne7, MD, PhD; Patrick W. Serruys8, MD, PhD; Gregg W. Stone3,4, MD
1. Hospital Meixoeiro, University Hospital of Vigo, Vigo, Spain; 2. New York Methodist Hospital, Brooklyn, NY, USA; 3. Cardiovascular Research Foundation, New York, NY, USA; 4. New York-Presbyterian Hospital/Columbia University Medical Center, New York, N

Aims: Prior percutaneous coronary intervention (PCI) is increasingly encountered in acute coronary syndrome (ACS) patients, with uncertain significance. We sought to evaluate the impact o

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

acute coronary syndromesoutcomespercutaneous coronary interventionvirtual histology intravascular ultrasound
Coronary interventionsSTEMINSTEMIInvasive imaging and functional assessmentInvasive imaging and functional assessment
Read next article
Clinical outcomes following “off-label” versus “established” indications of bioresorbable scaffolds for the treatment of coronary artery disease in a real-world population

Latest news